Rifaximin ameliorates intestinal inflammation in cirrhotic patients with hepatic encephalopathy

Rifaximin (RFX) treatment can attenuate not only hyperammonemia but also Enterococcus faecalis translocation and 10‐7G values, suggesting that RFX treatment may improve intestinal inflammation and result in better overall survival.[Image: see text]

Na minha lista:
Detalhes bibliográficos
Publicado no:JGH Open
Main Authors: Tamai, Yasuyuki, Iwasa, Motoh, Eguchi, Akiko, Shigefuku, Ryuta, Kamada, Yoshihiro, Miyoshi, Eiji, Takei, Yoshiyuki
Formato: Artigo
Idioma:Inglês
Publicado em: Wiley Publishing Asia Pty Ltd 2021
Assuntos:
Brief Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8264230/
https://ncbi.nlm.nih.gov/pubmed/34263080
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jgh3.12596
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados